Ab Vision
Pharmaceuticals, 2528 Qume Drive, San Jose, California, 89557, United States, 11-50 Employees
Phone Number: 77********
Who is ABVISION
AbVision Inc. (AVI), previously the Drug Discovery Group of BioVision Inc., is a privately held biopharmaceutical company headquartered in the San Francisco Bay Area. AVIs most advanced d...
Read More
- Headquarters: 2528 Qume Drive, San Jose, California, 89557, United States
- Date Founded: 2018
- Employees: 11-50
- Revenue: $25 Million to $50 Million
- Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8071
AbVision Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding AbVision
Answer: AbVision's headquarters are located at 2528 Qume Drive, San Jose, California, 89557, United States
Answer: AbVision's phone number is 77********
Answer: AbVision's official website is https://abvisioninc.com
Answer: AbVision's revenue is $25 Million to $50 Million
Answer: AbVision's SIC: 8071
Answer: AbVision has 11-50 employees
Answer: AbVision is in Pharmaceuticals
Answer: AbVision contact info: Phone number: 77******** Website: https://abvisioninc.com
Answer: AbVision Inc. (AVI), previously the Drug Discovery Group of BioVision Inc., is a privately held biopharmaceutical company headquartered in the San Francisco Bay Area. AVIs most advanced drug discovery efforts aim to develop pipelines of cancer and infectious disease therapeutics that harness the natural power of the immune system to bring first-in-class and best-in-class drugs to the world. AVI asks the question: How can we utilize AVIs antibody discoveries to facilitate the success in therapies? Frequently, the obstacles lie in the lack of enough sufficient antibody diversity for lead selection. AVI is ready with solutions that are based on our revolutionary approach to creating a diverse array of antibodies. With AVIs proprietary antibody discovery platform, we are one of leading biopharmaceutical companies to have generated therapeutic and diagnostic antibodies from variety of conventional animals. AVI also pioneered the use of high-throughput reporter cell systems for functional screening of drug candidates. Furthermore, our computer surfacing technology for antibody can work not only in antibody humanization but also in antibody sequence optimization that greatly enhances solubility and stability for excellent manufacturing of drug candidates. AVIs deep expertise in antibody discovery, protein expression and robust drug screening platforms allow us to identify exceptionally selective, high-affinity antibodies, which can be applied as mono-agents or chimeric antigen receptors in therapies. Our breakthroughs have led to several therapeutic candidates currently in preclinical trials.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month